The federal government is, for the first time, funding a pilot program that will provide generic pre-exposure prophylaxis (PrEP) medications to prevent HIV. Specifically, the Centers for Disease Control and Prevention (CDC) has made about $10 million available for PrEP programs in jurisdictions already receiving funding for the Ending the HIV Epidemic in the United States initiative.